# Cabotegravir-Hormone PK/PD Interactions for HIV Prevention

> **NCT07672717** · PHASE1 · RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 32 (estimated)

## Conditions studied

- HIV
- Prophylaxis
- Injectable

## Interventions

- **DRUG:** Cabotegravir Injectable Suspension (CAB LA)

## Key facts

- **NCT ID:** NCT07672717
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-07
- **Primary completion:** 2030-12
- **Final completion:** 2031-12
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2026-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07672717

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07672717, "Cabotegravir-Hormone PK/PD Interactions for HIV Prevention". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07672717. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*